[The Munich cryopreserved sperm bank--intermediate 1974-1986 evaluation]

Area of Science:

• Oncology
• Reproductive Medicine
• Cryobiology

Background:

• Sperm banking is crucial for preserving fertility in cancer patients undergoing treatments that may impair reproductive function.
• Early diagnosis and treatment of testicular tumors and Hodgkin's disease lead to excellent survival rates, but often at the cost of fertility.
• A sperm bank at the University of Munich's Dermatology Department has served primarily men with testicular tumors since 1974.

Observation:

• A 12-year review analyzed patient demographics, reasons for sperm storage, cryopreservation methods, and the success of insemination with cryopreserved samples.
• The study focused on male patients, particularly those with testicular tumors, utilizing the established sperm bank services.
• Data collection covered patient profiles, indications for sperm preservation, cryopreservation techniques, and outcomes of insemination procedures.

Findings:

• Cryopreserved sperm samples from cancer patients, including those with testicular tumors, have been successfully used for insemination.
• The study provides insights into the patient population, storage indications, and preservation methods employed over a 12-year period.
• Optimal results from using cryopreserved sperm for insemination are achieved when performed by gynecologists with specialized experience in sterility treatment.

Implications:

• Sperm banking offers a viable option for maintaining reproductive potential in cancer survivors.
• The findings underscore the importance of specialized gynecological expertise for successful assisted reproductive technologies utilizing cryopreserved sperm.
• Continued research and clinical practice in sperm cryopreservation are vital for supporting the fertility needs of oncology patients.